Although numerous epidemiological studies have shown that inorganic arsenic
als cause skin cancers and hyperkeratoses in humans, there are currently no
established mechanisms for their action or animal models, previous studies
in our laboratory using primary human keratinocyte cultures demonstrated t
hat micromolar concentrations of inorganic arsenite increased cell prolifer
ation via the production of keratinocyte-derived growth factors. As recent
reports demonstrate that overexpression of keratinocyte-derived growth fact
ors, such as transforming growth factor (TGF)-alpha, promote the formation
of skin tumors, we hypothesized that similar events may be responsible for
those associated with arsenic skin diseases. Thus, the influence of arsenic
in humans with arsenic skin disease and on mouse skin tumor development in
transgenic mice was studied. After low-dose application of tetradecanoyl p
horbol acetate (TPA), a marked increase in the number of skin pap illomas o
ccurred in Tg,AC mice, which carry the v-Ha-ras oncogene, that received ars
enic in the drinking water as compared with control drinking water, whereas
no papillomas developed in arsenic-treated transgenic mice that did not re
ceive TPA or arsenic/TPA-treated wild-type FVB/N mice. Consistent with earl
ier in vitro findings, increases in granulocyte/macrophage colony-stimulati
ng factor (GM-CSF) and TGF-alpha mRNA transcripts were found in the epiderm
is at clinically normal sites within 10 weeks after arsenic treatment, Immu
nohistochemical staining localized TGF-alpha overexpression to the hair fol
licles, Injection of neutralizing antibodies to GM-CSF after TPA applicatio
n reduced the number of papillomas in Tg,AC mice. Analysis of gene expressi
on in samples of skin lesions obtained from humans chronically exposed to a
rsenic via their drinking water also showed similar alterations in growth f
actor expression. Although confirmation will be required in nontransgenic m
ice, these results suggest that arsenic enhances development of skin neopla
sias via the chronic stimulation of keratinocyte-derived growth factors and
may be a rare example of a chemical carcinogen that acts as a co-promoter.